| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. | Director | Common Stock | 108K | $205K | $1.91 | Jun 5, 2024 | Direct |
| XERIS PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 0 | Oct 5, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
| XERS | Xeris Biopharma Holdings, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
| XERS | Xeris Biopharma Holdings, Inc. | Jun 8, 2022 | 2 | $31.5K | 4 | Jun 9, 2022 | Director |
| XERS | Xeris Biopharma Holdings, Inc. | Oct 5, 2021 | 4 | $0 | 4 | Oct 5, 2021 | Director |
| XERS | XERIS PHARMACEUTICALS INC | Oct 5, 2021 | 4 | $0 | 4 | Oct 5, 2021 | Director |
| XERS | Xeris Biopharma Holdings, Inc. | Oct 5, 2021 | 0 | $0 | 3 | Oct 5, 2021 | Director |
| XERS | XERIS PHARMACEUTICALS INC | Jun 8, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |